News
DealMonitor: 468 invests in Gauss Robotics – Exazyme secures €2 million – D2C Angels bet on ingarden
Exazyme secures €2 million investment from AIX Ventures and Atlantic Labs. As a Berlin-based AI-Biotech startup, founded in 2022 by Ingmar Schuster, Philipp Markert, and Dr. Jelena Ivanovska, we leverage AI-based solutions to identify the optimal protein variations for diverse applications. Through training the AI with datasets, the team predicts the properties of novel protein variants.
Read full article here: https://www.deutsche-startups.de/2023/05/15/dealmonitor-gauss-robotics-exazyme/
DEUTSCHE STARTUPS, 15. Mai 2023
More from Exazyme
- Success Story/
Max-Planck Institute
Discover how Exazyme’s machine learning solutions dramatically improved the performance of the GCC enzyme, increasing carbon fixation rates by 2.8 times and reducing energy demand by 60%.
Read More
- News/
Exazyme partners with Ginkgo Bioworks and becomes part of the Ginkgo Technology Network
Exazyme partners with Ginkgo Bioworks, joining the Ginkgo Technology Network to empower R&D teams with AI-driven protein engineering solutions.
Read More